Acromus 0.1% Eye Ointment
Acromus 0.1% Eye Ointment decreases the production of inflammatory chemicals by certain immune cells (T lymphocytes) and relieves redness and swelling. Never use Acromus 0.1% Eye Ointment if the seal is broken before you use it for the first time. Wash your hands before using it. Follow the instructions given by your doctor and use it in the dose and duration suggested by the doctor. Make sure you remove contact lenses if you wear them and wait for at least 15 minutes before putting them back. You must inform your doctor if there’s no improvement even after two weeks of treatment or if it gets worse.
Acromus 0.1% Eye Ointment
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Acromus 0.1% Eye Ointment is a medicine used to treat allergic eye disease. It also prevents rejection after corneal transplant surgery. It works by suppressing the action of a protein (calcineurin).
Acromus 0.1% Eye Ointment decreases the production of inflammatory chemicals by certain immune cells (T lymphocytes) and relieves redness and swelling. Never use Acromus 0.1% Eye Ointment if the seal is broken before you use it for the first time. Wash your hands before using it. Follow the instructions given by your doctor and use it in the dose and duration suggested by the doctor. Make sure you remove contact lenses if you wear them and wait for at least 15 minutes before putting them back. You must inform your doctor if there’s no improvement even after two weeks of treatment or if it gets worse.
The most common side effects of Acromus 0.1% Eye Ointment include eye irritation and burning sensation. Do not use Acromus 0.1% Eye Ointment if you are pregnant or trying to become pregnant, or if you are breastfeeding.
03Uses
Allergic eye disease
Prevention of organ rejection in transplant patients
04How To Use
This medicine is for external use only. Take it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the tube close to the eye without touching it. Gently squeeze the tube and place the medicine inside the lower eyelid.
05How It Works
Acromus 0.1% Eye Ointment is an immunomodulator. It works by suppressing the action of a protein (calcineurin). This decreases the production of inflammatory chemicals by certain immune cells (T lymphocytes). This relieves allergic eye symptoms.
06What If You Miss A Dose?
If you miss a dose of Acromus 0.1% Eye Ointment, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Benefits
In Allergic eye disease
Acromus 0.1% Eye Ointment belongs to a group of medicines known as immunosuppressive agents. It helps relieve symptoms of allergic eye disease such as redness, swelling, itching, and watering of eyes. This medicine works by decreasing the production of certain chemicals that cause inflammation. This will make it easier for you to go about your daily activities. Use it as prescribed to get the most benefit. If you see no improvement even after 2 weeks, talk to your doctor.
In Prevention of organ rejection in transplant patients
Acromus 0.1% Eye Ointment belongs to a group of medicines known as immunosuppressants. Organ rejection happens when your immune system treats the new organ as an invader and attacks it. This medicine weakens your immune response (which usually fights infection) and reduces the chance of your body attacking the transplanted organ. It is used in combination with other medicines to make it much more likely that your transplant operation will be successful. You should continue taking the medicine and should not stop it until your doctor says so.show moreshow less
08Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Stomach pain
Nausea
Liver damage
Kidney damage
Increased thirst
Increased glucose level in blood
Diarrhea
Burning sensation
Eye irritation
09Safety Information
Alcohol:
No interaction found/established
Pregnancy:CONSULT YOUR DOCTOR
Acromus 0.1% Eye Ointment may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding:SAFE IF PRESCRIBED
Acromus 0.1% Eye Ointment is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving:UNSAFE
Acromus 0.1% Eye Ointment may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney:
No interaction found/established
Liver:
No interaction found/established
10Drug Tips
You have been prescribed Acromus 0.1% Eye Ointment to treat inflammation (redness and swelling) due to allergies of the eye.
If you wear soft contact lenses, remove them before using Acromus 0.1% Eye Ointment and wait at least 15 minutes before putting your lenses back in.
Do not touch the tip to any surface, or to your eye, to avoid contamination.
It may cause minor burning, stinging, or irritation in the eye. Inform your doctor if this does not go away.
Consult your doctor if your eye condition has not improved after two weeks of treatment or if it gets worse.
Continuous long-term use of the ointment should be avoided.
References
Sources and references
Burkhart C, Morrell D, Goldsmith L. Dermatological Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1822.
Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 972.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1305-309.
Tacrolimus monohydrate. Camberley, Surrey: Sandoz Limited; 2010 . view
Central Drugs Standard Control Organisation . view
